VIGIL NEUROSCIENCE INC (VIGL) Fundamental Analysis & Valuation
NASDAQ:VIGL • US92673K1088
Current stock price
8.05 USD
0 (0%)
At close:
8.09 USD
+0.04 (+0.5%)
After Hours:
This VIGL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. VIGL Profitability Analysis
1.1 Basic Checks
- In the past year VIGL has reported negative net income.
- VIGL had a negative operating cash flow in the past year.
- VIGL had negative earnings in each of the past 5 years.
- VIGL had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -80.94%, VIGL is doing worse than 69.57% of the companies in the same industry.
- VIGL's Return On Equity of -133.18% is on the low side compared to the rest of the industry. VIGL is outperformed by 60.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -80.94% | ||
| ROE | -133.18% | ||
| ROIC | N/A |
ROA(3y)-54.78%
ROA(5y)-63.89%
ROE(3y)-74.94%
ROE(5y)-84.7%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for VIGL so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. VIGL Health Analysis
2.1 Basic Checks
- Compared to 1 year ago, VIGL has more shares outstanding
- VIGL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- VIGL has an Altman-Z score of -1.10. This is a bad value and indicates that VIGL is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of VIGL (-1.10) is comparable to the rest of the industry.
- There is no outstanding debt for VIGL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.1 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- VIGL has a Current Ratio of 2.97. This indicates that VIGL is financially healthy and has no problem in meeting its short term obligations.
- VIGL has a worse Current ratio (2.97) than 65.22% of its industry peers.
- A Quick Ratio of 2.97 indicates that VIGL has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 2.97, VIGL is doing worse than 63.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.97 | ||
| Quick Ratio | 2.97 |
3. VIGL Growth Analysis
3.1 Past
- VIGL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.42%.
EPS 1Y (TTM)1.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.69%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- The Earnings Per Share is expected to grow by 18.25% on average over the next years. This is quite good.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y20.49%
EPS Next 2Y4.87%
EPS Next 3Y-1.63%
EPS Next 5Y18.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. VIGL Valuation Analysis
4.1 Price/Earnings Ratio
- VIGL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VIGL. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.87%
EPS Next 3Y-1.63%
5. VIGL Dividend Analysis
5.1 Amount
- No dividends for VIGL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
VIGL Fundamentals: All Metrics, Ratios and Statistics
8.05
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-03 2025-11-03
Inst Owners67.08%
Inst Owner ChangeN/A
Ins Owners0.51%
Ins Owner Change0%
Market Cap375.69M
Revenue(TTM)N/A
Net Income(TTM)-86.73M
Analysts52.31
Price Target8.16 (1.37%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.88%
Min EPS beat(2)-5.67%
Max EPS beat(2)9.42%
EPS beat(4)3
Avg EPS beat(4)6.62%
Min EPS beat(4)-5.67%
Max EPS beat(4)15.41%
EPS beat(8)6
Avg EPS beat(8)7.04%
EPS beat(12)10
Avg EPS beat(12)8.96%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-48.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.95%
EPS NY rev (1m)0%
EPS NY rev (3m)11.09%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 5.77 | ||
| P/tB | 5.77 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.09
EYN/A
EPS(NY)-1.85
Fwd EYN/A
FCF(TTM)-1.15
FCFYN/A
OCF(TTM)-1.14
OCFYN/A
SpS0
BVpS1.4
TBVpS1.4
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -80.94% | ||
| ROE | -133.18% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-54.78%
ROA(5y)-63.89%
ROE(3y)-74.94%
ROE(5y)-84.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 62.5% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.97 | ||
| Quick Ratio | 2.97 | ||
| Altman-Z | -1.1 |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)440.01%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.69%
EPS Next Y20.49%
EPS Next 2Y4.87%
EPS Next 3Y-1.63%
EPS Next 5Y18.25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-33.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y24.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.07%
OCF growth 3YN/A
OCF growth 5YN/A
VIGIL NEUROSCIENCE INC / VIGL Fundamental Analysis FAQ
What is the ChartMill fundamental rating of VIGIL NEUROSCIENCE INC (VIGL) stock?
ChartMill assigns a fundamental rating of 2 / 10 to VIGL.
Can you provide the valuation status for VIGIL NEUROSCIENCE INC?
ChartMill assigns a valuation rating of 0 / 10 to VIGIL NEUROSCIENCE INC (VIGL). This can be considered as Overvalued.
What is the profitability of VIGL stock?
VIGIL NEUROSCIENCE INC (VIGL) has a profitability rating of 0 / 10.
Can you provide the expected EPS growth for VIGL stock?
The Earnings per Share (EPS) of VIGIL NEUROSCIENCE INC (VIGL) is expected to grow by 20.49% in the next year.